The Technical Analyst
Select Language :
NGM Biopharmaceuticals [NGM]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

NGM Biopharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

NGM Biopharmaceuticals is listed at the  Exchange

-1.85% $1.590

America/New_York / 28 mar 2024 @ 16:00


NGM Biopharmaceuticals: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 132.71 mill
EPS: -1.730
P/E: -0.920
Earnings Date: May 01, 2024
SharesOutstanding: 83.46 mill
Avg Daily Volume: 1.476 mill
RATING 2024-03-28
B-
Sell
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Sell
DE: Sell
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.920 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.16x
Company: PE -0.920 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.611
(-61.59%) $-0.979
Date: 2024-03-28
Expected Trading Range (DAY)

$ 1.480 - 1.700

( +/- 6.92%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-01-16 Lieu Hsiao D Sell 5 430 Common Stock
2024-01-16 Perlich Irene Sell 1 025 Common Stock
2024-01-16 Pierce Valerie L Sell 5 021 Common Stock
2024-01-16 Woodhouse David J Sell 13 032 Common Stock
2023-12-01 Viret Jean-frederic Buy 450 000 Stock Option (Right to Buy)
INSIDER POWER
20.80
Last 100 transactions
Buy: 7 498 618 | Sell: 3 944 518

Forecast: 16:00 - $1.580

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $1.580
Forecast 2: 16:00 - $1.580
Forecast 3: 16:00 - $1.580
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $1.590 (-1.85% )
Volume 0.357 mill
Avg. Vol. 1.476 mill
% of Avg. Vol 24.20 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for NGM Biopharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for NGM Biopharmaceuticals Inc

RSI

Intraday RSI14 chart for NGM Biopharmaceuticals Inc

Last 10 Buy & Sell Signals For NGM

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:32buy$1.431N/AActive
Profile picture for
            NGM Biopharmaceuticals Inc

NGM

NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); and MK-3655, an agonistic antibody that activates fibroblast growth factor receptor 1c-beta-klotho, which is in Phase IIb clinical trials for use in the treatment of type 2 diabetes and NASH. Its products under development also comprise NGM120, an antagonist antibody that binds GFRAL that is in Phase I/II clinical trials; NGM621, an immunoglobulin 1 monoclonal antibody in Phase II clinical trials for the treatment of geographic atrophy; NGM707, an immunoglobulin-like transcript 2/ immunoglobulin-like transcript 4 dual antagonist monoclonal antibody that is in Phase I/II clinical trials for the treatment of patients with advanced solid tumors; and NGM831 and NGM438 for the treatment of advanced solid tumors. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp.; and a collaboration agreement with Merck & Co., Inc. to focus primarily on the development of novel medicines for unmet patient needs in retinal and CVM diseases, including heart failure. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California.

Last 10 Buy Signals

Date Signal @
GLMUSDMar 29 - 02:58$0.690
YAKUSDMar 29 - 02:57834.25
UMAUSDMar 29 - 02:57$4.31
DIGGUSDMar 29 - 02:54891.16
BFICUSDMar 29 - 02:549.82
GRPUSDMar 29 - 02:5316.49
DPXUSDMar 29 - 02:4542.45
WBTUSDMar 29 - 02:428.37
TUSDUSDMar 29 - 02:41$0.994
BGBUSDMar 29 - 02:300.996

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.